T cells producing the anti-inflammatory cytokine IL-10 regulate allergen-specific Th2 responses in human airways

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 8, 2012, Pages 1007-1013

  Faith, A ^a   Singh, N ^b,c   Farooque, S ^a   Dimeloe, S ^a   Richards, D F ^a   Lu, H ^a   Roberts, D ^b   Chevretton, E ^b   Lee, T H ^a   Corrigan, C J ^a   Hawrylowicz, C M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Allergy; IL 10; Nasal polyp; T cell

Indexed keywords

ALLERGEN; CD16 ANTIGEN; CD45 ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 5; TRANSCRIPTION FACTOR FOXP3;

AIRWAY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; B LYMPHOCYTE; BIOCHEMICAL COMPOSITION; CELL ISOLATION; CHRONIC RHINITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; IMMUNOREGULATION; INHIBITION KINETICS; LEUKOCYTE; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NOSE POLYP; POLYPECTOMY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT MUCOSA; SUSPENSION; T CELL DEPLETION; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; AGED; ALLERGENS; CYTOKINES; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-5; LEUKOCYTES; MIDDLE AGED; NASAL POLYPS; RESPIRATORY MUCOSA; T-LYMPHOCYTES; TH2 CELLS; YOUNG ADULT;

EID: 84863826788     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2012.02852.x     Document Type: Article

References (30)

1. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004; 199: 1567-1575. (Pubitemid 38780411)
2. Hawrylowicz CM, O'Garra A,. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005; 5: 271-283. (Pubitemid 40516153)
3. Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J, et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004; 363: 608-615. (Pubitemid 38264178)
4. Maggi L, Santarlasci V, Liotta F, Frosali F, Angeli R, Cosmi L, et al. Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals. J Allergy Clin Immunol 2007; 120: 429-436. (Pubitemid 47411530)
5. Thunberg S, Akdis M, Akdis CA, Gronneberg R, Malmstrom V, Trollmo C, et al. Immune regulation by CD4+CD25+ T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls. Clin Exp Allergy 2007; 37: 1127-1136. (Pubitemid 47076340)
6. Nouri-Aria KT, Wachholz PA, Francis JN, Jacobson MR, Walker SM, Wilcock LK, et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol 2004; 172: 3252-3259. (Pubitemid 38263717)
7. Akdis CA, Blesken XX, Akdis M, Wuthrich B, Blaser K,. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998; 102: 98-106. (Pubitemid 28323835)
8. Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga J,. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 1997; 27: 1131-1139. (Pubitemid 27197215)
9. Bachert C, Van Bruaene N, Toskala E, Zhang N, Olze H, Scadding G, et al. Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis-a GALEN study. Allergy 2009; 64: 520-533.
10. Jutel M, Akdis CA,. Immunological mechanisms of allergen-specific immunotherapy. Allergy 2011; 66: 725-732.
11. Jaffar ZH, Stanciu L, Pandit A, Lordan J, Holgate ST, Roberts K,. Essential role for both CD80 and CD86 costimulation, but not CD40 interactions, in allergen-induced Th2 cytokine production from asthmatic bronchial tissue: role for alphabeta, but not gammadelta, T cells. J Immunol 1999; 163: 6283-6291.
12. Cameron L, Hamid Q, Wright E, Nakamura Y, Christodoulopoulos P, Muro S, et al. Local synthesis of epsilon germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa after ex vivo allergen exposure. J Allergy Clin Immunol 2000; 106 (1 Pt 1): 46-52. (Pubitemid 30482851)
13. Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH, et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002; 8: 1024-1032. (Pubitemid 35033708)
14. Strickland DH, Stumbles PA, Zosky GR, Subrata LS, Thomas JA, Turner DJ, et al. Reversal of airway hyperresponsiveness by induction of airway mucosal CD4+CD25+ regulatory T cells. J Exp Med 2006; 203: 2649-2660. (Pubitemid 44833341)
15. Verbruggen K, Van Cauwenberge P, Bachert C,. Anti-IgE for the treatment of allergic rhinitis-and eventually nasal polyps? Int Arch Allergy Immunol 2009; 148: 87-98.
16. Rinia AB, Kostamo K, Ebbens FA, van Drunen CM, Fokkens WJ,. Nasal polyposis: a cellular-based approach to answering questions. Allergy 2007; 62: 348-358. (Pubitemid 46398804)
17. Faith A, McDonald J, Peek E, Richards D, Caulfield J, Chevretton E, et al. Functional plasticity of human respiratory tract dendritic cells: GM-CSF enhances T(H)2 development. J Allergy Clin Immunol 2005; 116: 1136-1143. (Pubitemid 41571800)
18. Kirsche H, Niederfuhr A, Deutschle T, Fuchs C, Riechelmann H,. Ratio of myeloid and plasmacytoid dendritic cells and TH2 skew in CRS with nasal polyps. Allergy 2010; 65: 24-31.
19. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203: 1701-1711. (Pubitemid 44036276)
20. Huehn J, Siegmund K, Lehmann JC, Siewert C, Haubold U, Feuerer M, et al. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med 2004; 199: 303-313. (Pubitemid 38252043)
21. Sanchez-Segura A, Brieva JA, Rodriguez C,. T lymphocytes that infiltrate nasal polyps have a specialized phenotype and produce a mixed TH1/TH2 pattern of cytokines. J Allergy Clin Immunol 1998; 102 (6 Pt 1): 953-960. (Pubitemid 29018312)
22. Gri G, Piconese S, Frossi B, Manfroi V, Merluzzi S, Tripodo C, et al. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008; 29: 771-781.
23. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008; 28: 546-558.
24. Cho SH, Stanciu LA, Holgate ST, Johnston SL,. Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. Am J Respir Crit Care Med 2005; 171: 224-230.
25. Heaton T, Rowe J, Turner S, Aalberse RC, de Klerk N, Suriyaarachchi D, et al. An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet 2005; 365: 142-149. (Pubitemid 40091804)
26. Pilette C, Nouri-Aria KT, Jacobson MR, Wilcock LK, Detry B, Walker SM, et al. Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-beta expression. J Immunol 2007; 178: 4658-4666. (Pubitemid 46492419)
27. Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010; 32: 129-140.
28. Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ,. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007; 8: 1095-1104. (Pubitemid 47423757)
29. Rotzschke O, Borsellino G, Battistini L, Falk K, Kleinewietfeld M,. In vivo-activated CD103+ Foxp3+ Tregs: of men and mice. Blood 2009; 113: 2119-2120; author reply 20.
30. Kearley J, Barker JE, Robinson DS, Lloyd CM,. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med 2005; 202: 1539-1547. (Pubitemid 41746600)